These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6852923)

  • 61. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
    Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I
    Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
    Verheul AF; Versteeg AA; De Reuver MJ; Jansze M; Snippe H
    Infect Immun; 1989 Apr; 57(4):1078-83. PubMed ID: 2925240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
    Benaissa-Trouw B; Lefeber DJ; Kamerling JP; Vliegenthart JF; Kraaijeveld K; Snippe H
    Infect Immun; 2001 Jul; 69(7):4698-701. PubMed ID: 11402020
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
    Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
    Koskela M
    Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of a functionally distinct IgM anti-type III pneumococcal polysaccharide (SIII) in low-dose paralysis to SIII in mice.
    Kearney R; Andrews J; Johnstone S
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():19-35. PubMed ID: 2938567
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen.
    Jones JM; Amsbaugh DF; Prescott B
    J Immunol; 1976 Jan; 116(1):52-64. PubMed ID: 1446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4.
    Musher DM; Johnson B; Watson DA
    Infect Immun; 1990 Dec; 58(12):3871-6. PubMed ID: 2254015
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.
    Zigterman GJ; Snippe H; Jansze M; Ernste EB; De Reuver MJ; Willers JM
    Infect Immun; 1988 May; 56(5):1391-3. PubMed ID: 3356469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
    de Velasco EA; Merkus D; Anderton S; Verheul AF; Lizzio EF; Van der Zee R; Van Eden W; Hoffman T; Verhoef J; Snippe H
    Infect Immun; 1995 Mar; 63(3):961-8. PubMed ID: 7532630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3.
    Snippe H; van Dam JE; van Houte AJ; Willers JM; Kamerling JP; Vliegenthart JF
    Infect Immun; 1983 Nov; 42(2):842-4. PubMed ID: 6642655
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.
    Pawlowski A; Källenius G; Svenson SB
    Vaccine; 2000 Mar; 18(18):1873-85. PubMed ID: 10699336
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Immunoglobulin M Response to Pneumococcal Polysaccharide Vaccine Is Sufficient for Conferring Immunity.
    Cravens MP; Alugupalli AS; Sandilya VK; McGeady SJ; Alugupalli KR
    J Infect Dis; 2022 Nov; 226(10):1852-1856. PubMed ID: 35932228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI; Sarwar J; Ortiz A; Naso R
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines.
    Colling RG; Pearson TC; Brown JC
    Infect Immun; 1983 Jul; 41(1):205-13. PubMed ID: 6345390
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and delivery of
    Su H; Liu Q; Bian X; Wang S; Curtiss R; Kong Q
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33380455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.